Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 7Melanoma 5Leukemia 5Colonic Neoplasms 5Rectal Neoplasms 4Leukemia, Myeloid, Acute 4Urinary Bladder Neoplasms 3Prostatic Neoplasms 3Lymphoma, Follicular 3Fallopian Tube Neoplasms 3Congenital Abnormalities 3Colorectal Neoplasms 3Carcinoma, Ovarian Epithelial 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Ovarian Neoplasms 2Myelodysplastic Syndromes 2Mesothelioma, Malignant 2Lymphoma 2Lung Neoplasms 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Head and Neck Neoplasms 2Waldenstrom Macroglobulinemia 1

Interventions

Magnetic Resonance Spectroscopy 7X-Rays 6Vincristine 6Phantoms, Imaging 6Cyclophosphamide 6Specimen Handling 5Nuclear Medicine Department, Hospital 5Ifosfamide 5Etoposide 5Biopsy 5Temozolomide 4Radiotherapy 4Doxorubicin 4Dactinomycin 4Topotecan 3Melphalan 3Irinotecan 3Filgrastim 3Carboplatin 3Busulfan 3ulixertinib 2tipifarnib 2tazemetostat 2tanespimycin 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ixabepilone 2ivosidenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Neuroectodermal Tumors, Primitive, Peripheral × Gene Expression Profiling × Clear all
NCT00514345 2013-08-12

CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide

National Cancer Institute (NCI)

Unknown
300 enrolled
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡